Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkyl...

por Pujol, J-L, Carestia, Daurès, J-P
Publicado 2000

The JAK/STAT pathway but not the Erk1/2 pathway mediates IL-6/sIL-6R downregulation of type II collagen, aggrecan core and link protein transcription in articular chondrocytes

por Bogdanowicz, P, Legendre, F, Dudhia, J, Pujol, J-P
Publicado 2003

Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data

por Choma, D, Daurès, J-P, Quantin, X, Pujol, J L
Publicado 2001

Markov model and markers of small cell lung cancer: assessing the influence of reversible serum NSE, CYFRA 21-1 and TPS levels on prognosis

por Boher, J-M, Pujol, J-L, Grenier, J, Daurès, J-P
Publicado 1999

Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer

por Jacot, W, Pujol, J-L, Boher, J-M, Lamy, P-J
Publicado 2004

NFκB mediates IL-1β-induced down-regulation of TβRII through the modulation of Sp3 expression

por Baugé, C, Beauchef, G, Leclercq, S, Kim, S J, Pujol, J P, Galéra, P, Boumédiene, K
Publicado 2008

A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index

por Colinet, B, Jacot, W, Bertrand, D, Lacombe, S, Bozonnat, M-C, Daurès, J-P, Pujol, J-L
Publicado 2005

Clinical evaluation of serum tumour marker CA 242 in non-small cell lung cancer.

por Pujol, J. L., Cooper, E. H., Lehmann, M., Purves, D. A., Dan-Aouta, M., Midander, J., Godard, P., Michel, F. B.
Publicado 1993

Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors

por Jacot, W, Quantin, X, Boher, J-M, Andre, F, Moreau, L, Gainet, M, Depierre, A, Quoix, E, Chevalier, T Le, Pujol, J-L
Publicado 2001

Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.

por Pujol, J. L., Monnier, A., Berille, J., Cerrina, M. L., Douillard, J. Y., Rivière, A., Grandgirard, A., Gouva, S., Bizzari, J. P., Le Chevalier, T.
Publicado 1994

Hypodiploidy, Ki-67 growth fraction and prognosis of surgically resected lung cancers.

por Pujol, J. L., Simony, J., Jolimoy, G., Jaffuel, D., Demoly, P., Quantin, X., Marty-Ané, C., Boher, J. M., Charpentier, R., Michel, F. B.
Publicado 1996

Region-specific alterations of A-to-I RNA editing of serotonin 2c receptor in the cortex of suicides with major depression

por Weissmann, D, van der Laan, S, Underwood, M D, Salvetat, N, Cavarec, L, Vincent, L, Molina, F, Mann, J J, Arango, V, Pujol, J F
Publicado 2016

RNA editing blood biomarkers for predicting mood alterations in HCV patients

por Salvetat, N., Van der Laan, S., Vire, B., Chimienti, F., Cleophax, S., Bronowicki, J. P., Doffoel, M., Bourlière, M., Schwan, R., Lang, J. P., Pujol, J. F., Weissmann, D.
Publicado 2019

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

por Pujol, J-L, Molinier, O, Ebert, W, Daurès, J-P, Barlesi, F, Buccheri, G, Paesmans, M, Quoix, E, Moro-Sibilot, D, Szturmowicz, M, Bréchot, J-M, Muley, T, Grenier, J
Publicado 2004

Consensus of the Spanish society of laboratory medicine and the Spanish society of medical oncology on the methodology and criteria for evaluation of circulating tumour markers in...

por Ayala de la Peña, F., Ortiz-Muñoz, B., Quintanar-Verdúguez, T., Santotoribio, J. D., de la Cruz, S., Trapé-Pujol, J., Galve-Calvo, E., Augé-Fradera, J. M., García-Gómez, J., González-Hernández, Á.
Publicado 2021

Brain volumetric and metabolic correlates of electroconvulsive therapy for treatment-resistant depression: a longitudinal neuroimaging study

por Cano, M, Martínez-Zalacaín, I, Bernabéu-Sanz, Á, Contreras-Rodríguez, O, Hernández-Ribas, R, Via, E, de Arriba-Arnau, A, Gálvez, V, Urretavizcaya, M, Pujol, J, Menchón, J M, Cardoner, N, Soriano-Mas, C
Publicado 2017

Summary report of the Standards, Options and Recommendations for the management of patients with non-small-cell lung carcinoma (2000)

por Depierre, A, Lagrange, J L, Theobald, S, Astoul, P, Baldeyrou, P, Bardet, E, Bazelly, B, Bréchot, J M, Breton, J L, Douillard, J Y, Grivaux, M, Jacoulet, P, Khalil, A, Lemarié, E, Martinet, Y, Massard, G, Milleron, B, Molina, T, Moro-Sibilot, D, Paesmans, M, Pujol, J L, Quoix, E, Ranfaing, E, Rivière, A, Sancho-Garnier, H, Souquet, P J, Spaeth, D, Stœbner-Delbarre, A, Thiberville, L, Touboul, E, Vaylet, F, Vergnon, J M, Westeel, V
Publicado 2003